| abstract |
The invention relates to 7- (1,1-dimethylethyl) -6- (2-ethyl-2H-1,2,4-triazol-3-ylmethoxy) -3- (2-fluorophenyl) -1,2,4- triazolo {4,3-b} pyridazine and its pharmaceutically acceptable salts, which are a selective ligand for GABAA receptors, in particular having high affinity for the alpha 2 and / or alpha 3 subunit, and are useful in the treatment and prevention of CNS disorders system involving anxiety and convulsions. |